Fabien Audibert

Title: Fabien Audibert: Innovator in Dermatological Treatments

Introduction

Fabien Audibert is a notable inventor based in Roquette-sur-Siagne, France. He has made significant contributions to the field of dermatology, particularly in the treatment of rosacea. His innovative approach combines established medications to enhance treatment efficacy.

Latest Patents

Audibert holds a patent for the "Use of ivermectin and brimonidine in the treatment and/or prevention of moderate to severe rosacea." This invention focuses on a combination therapy that utilizes a 1% ivermectin cream and a 0.33% brimonidine gel for topical administration. This combination aims to provide effective relief for patients suffering from this skin condition.

Career Highlights

Throughout his career, Fabien Audibert has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Galderma Holding SA and Galderma S.A., where he has contributed to the development of innovative dermatological solutions.

Collaborations

Audibert has collaborated with several professionals in his field, including Philippe Martel and Nabil Kerrouche. These partnerships have likely enriched his research and development efforts, leading to advancements in treatment options.

Conclusion

Fabien Audibert's work exemplifies the impact of innovation in medical treatments, particularly in dermatology. His patent for the combination of ivermectin and brimonidine represents a significant step forward in addressing moderate to severe rosacea.